Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fractional co2 Laser Followed by Either Vitamin c or Tranexamic Acid in Treatment of Melasma. Asplit Face Dermoscopic and Clinical Study.

NCT05911698 is registered in ClinicalTrials.gov with Khadija Qenawi as lead sponsor.

NCT NCT05911698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05911698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fractional co2 Laser Followed by Either Vitamin c or Tranexamic Acid in Treatment of Melasma. Asplit Face Dermoscopic and Clinical Study.
Lead sponsor
Khadija Qenawi
Phase
Not applicable
Overall status
Unknown status
Start date
October 28, 2023
Completion date
March 31, 2024
Enrollment
25 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

melasma